Neuland Laboratories Ltd - Artha Sootra

Overview (04 Nov 2026)

Neuland Laboratories Ltd

NEULANDLAB

INE794A01010

Pharmaceuticals

179.1

Prev. Close

Previous Close

19435.2

Current Close

19614.3

Current High

19850

Current Low

18577.85

52 Week High

24235.05

52 Week Low

11500

Resistance 1

20116.91

Resistance 2

20619.53

Support 1

18844.76

Support 2

17572.61

Std Deviation

7.89%

DMA 200

17440.59

DMA 50

21526.17

DMA 20

19826.39

Fundamentals and Ratios

Standalone

Trailing EPS

283.01

Forwad EPS

427.15

Trailing P/E

69.31

Forward P/E

45.92

PEG Ratio

Mkt. Cap (Cr)

Market Cap (Cr)

25164.93

Total Debt(Cr)

Tot. Debt(Cr)

NA

Reserve (Cr)

NA

Book Value

NA

P/BV Ratio

NA

ROCE(%)

N/A

ROE

N/A

Financial Result

Standalone

Type	Sep-26	Jun-26	Mar-26	Dec-25	Sep-25	FY25-26
Revenue	449.66	641.58	776.25	439.71	514.27	2022.99
Other Income	7.49	8.49	12.46	8.05	1.80	30.16
Total Income	457.15	650.07	788.71	447.76	516.07	2053.15
Interest	7.31	6.97	7.23	6.79	5.34	23.95
Expenditure	-388.67	-452.53	-501.66	-393.49	-387.03	-1565.42
PBDT	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	-28.77	-26.56	-25.09	-23.92	-22.54	-91.73
PBT	68.48	197.54	287.04	54.27	129.04	487.73
Tax	-17.35	-50.17	-74.52	-13.86	-32.58	-124.63
Equity	12.90	12.90	12.90	12.90	0.00	12.90
OPM	14.98	30.39	36.39	12.12	25.09	23.76
Net Profit	51.13	147.36	212.52	40.42	96.46	363.11
NPM	11.18	22.67	26.95	9.03	18.76	17.69
EPS	39.85	114.86	165.65	31.5	75.18	283.01

Consolidated

Type	Sep-26	Jun-26	Mar-26	Dec-25	Sep-25	FY25-26
Revenue	449.66	641.58	776.25	439.71	514.27	2022.99
Other Income	7.50	8.49	12.46	8.05	1.80	30.17
Total Income	457.15	650.07	788.71	447.76	516.07	2053.15
Interest	7.31	6.97	7.21	6.79	5.37	23.95
Expenditure	-388.17	-452.22	-501.21	-393.29	-386.64	-1564.17
PBDT	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	-28.77	-26.56	-25.09	-23.92	-22.54	-91.74
PBT	68.98	197.85	287.49	54.48	129.44	488.98
Tax	-17.35	-50.17	-74.82	-13.90	-32.58	-124.98
Equity	12.90	12.90	12.90	0.00	0.00	12.90
OPM	15.09	30.44	36.45	12.17	25.08	23.82
Net Profit	51.63	147.67	212.67	40.57	96.85	364
NPM	11.29	22.72	26.96	9.06	18.77	17.73
EPS	40.24	115.1	165.76	31.62	75.49	283.71

Annual Reports

Corporate Action

Quarterly Result

Dividend

Year	Dividend Type	Amount	Remark	Ex Date
2026	Final Dividend	34.00	Final Dividend - Rs. - 34.0000	24 Jul 2026
2025	Final Dividend	12.00	Final Dividend - Rs. - 12.0000	18 Jul 2025
2024	Final Dividend	14.00	Final Dividend - Rs. - 14.0000	12 Jul 2024
2023	Final Dividend	10.00	Final Dividend - Rs. - 10.0000	11 Jul 2023
2022	Final Dividend	5.00	Final Dividend - Rs. - 5.0000	14 Jul 2022
2021	Final Dividend	3.00	Final Dividend - Rs. - 3.0000	29 Jun 2021
2021	Interim Divvidend	2.00	Interim Dividend - Rs. - 2.0000	10 Nov 2020
2020	Interim Divvidend	2.00	Interim Dividend - Rs. - 2.0000	18 Feb 2020
2019	Final Dividend	1.20	Dividend - Rs. - 1.2000	27 Jun 2019
2016	Final Dividend	2.00	Dividend - Rs. - 2.0000	04 Aug 2016
2015	Final Dividend	1.50	Dividend - Rs. - 1.5000	06 Aug 2015
2014	Final Dividend	1.50	Dividend - Rs. - 1.5000	16 Jun 2014
2014	Special Dividend	1.50	Special Dividend - Rs. - 1.5000	16 Jun 2014
2013	Final Dividend	1.20	Dividend - Rs. - 1.2000	24 Jul 2013
2009	Final Dividend	3.50	Dividend - Rs. - 3.5000	13 Jul 2009
2008	Final Dividend	2.50	Dividend - Rs. - 2.5000	17 Jul 2008

Bonus

Split

Mutual Fund Holddings

Sector peers

Sector: Pharmaceuticals

Company

Current Close

P/E Ratio

1773.4

130.40

10037.5

90.60

4738.5

83.32

2323.8

120.09

1188.1

38.84

1374

413.86

1402

42.73

2537.9

45.48

1705

36.07

2008.6

16.42

1